Dec 26, 2019
This podcast discusses the results and implications of a recent study on gender bias in speaker introductions at an international oncology conference.
This JCO Podcast provides observations and commentary on the JCO article "Evaluating Unconscious Bias: Speaker Introductions at an International Oncology Conference" by...
Dec 10, 2019
Treatment-free survival is a novel endpoint in immunotherapy.
TRANSCRIPT
This JCO Podcast provides observations and commentary on the JCO article “Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition—A Pooled Analysis of Patients With Advanced Melanoma” by Regan et al. My...
Dec 1, 2019
TRANSCRIPT
This JCO Podcast provides observations and commentary on the JCO article “Progression of Disease Within 24 Months (POD24) in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune-Infiltration” by Dr. Tobin and colleagues. My name is Dr. Carla Casulo, and I am Associate Professor of Medicine,...
Nov 20, 2019
This podcast summarizes the findings of the Lunenburg Lymphoma Biomarker Consortium systematic evaluation of MYC rearrangements in DLBCL, and discusses the prognostic impact of MYC, BCL2 and BCL6 rearrangements, and implications for FISH testing in newly diagnosed DLBCL.
TRANSCRIPT
This JCO Podcast provides...
Nov 10, 2019
This podcast discusses the work of Sheetz and colleagues describing the impact of centralization of high-risk cancer surgery within health care systems and networks in the United States.
TRANSCRIPT
This JCO Podcast provides observations and commentary on the JCO article “Centralization of High-Risk Cancer...